Dispersion Delivery TRIZ Cases

Gd.DOTA.DSA liposomes enhance tumor MRI signal via EPR accumulation, reducing liver toxicity.

Alanylglutamine composition resolves solubility and stability trade-offs to enhance concentration via optimized parameter changes.

Antimicrobial peptides strengthen immature gut and lung barriers, reducing necrotizing enterocolitis risk.

A dry flowable composition prevents agglomeration and foam by using a water-soluble sugar carrier and separating agent for rapid dissolution.

Chitosan mediates decursinol solubility to inhibit vascular smooth muscle cell proliferation.

Non-ionic surfactants form micellar assemblies that solubilize lipophilic natural compounds, overcoming poor gastrointestinal absorption.

Segmented beads with HPMCAS coatings resolve the contradiction between ease of oral administration and chemical stability in acidic media.

Ethanol and glycerine solubilize nifedipine in an oral liquid composition, eliminating polyethylene glycol toxicity risks while improving bioavailability.

Inhaled molgramostim replaces invasive whole lung lavage to treat autoimmune pulmonary alveolar proteinosis without anesthesia morbidity.

Micro-fibrillated cellulose serves as the exclusive disintegrator, enabling 80-90 wt% active ingredient concentration while maintaining tablet hardness.

Using an acidic soft drink at pH 2 to 3.5 optimizes prolyl endopeptidase catalysis, reducing required enzyme doses and alleviating gastrointestinal discomfort.

A solid drink formulation combines multiple herbal extracts with food-grade carriers to create a palatable health product.

A portable vaporization system uses a calibrated heating element to generate smokeless cannabinoid aerosols from interchangeable cartridges.

An optimized aerosol solution uses 1M HCl and ethanol to stabilize glycopyrronium bromide and formoterol, preventing degradation and extending shelf-life.

Mucin-interacting agents form an in-situ physical barrier in the duodenum to disrupt neurohormonal signaling pathways.

A pH buffering system maintains a 4 to 8 range to protect GLP-1 receptor agonists from pepsin degradation during oral administration.

Heat-activated Bacillus spores bypass harsh gastric conditions to colonize the intestine, reducing C-reactive protein levels.

A powder formulation combines alpha-lactalbumin and maltodextrins to bind butyric acid salts.

A nanoemulsion composition delivers aeroallergens to modulate immune responses and reduce airway inflammation.

ClpB protein mimics alpha-MSH to activate MC4R pathways, resolving insufficient satiety induction in obesity treatments.

Citrate and sorbate salts adjust pH to 5.8-6.1, resolving stability issues in extemporaneous suspensions.

Inhaled tissue plasminogen activator dissolves fibrin-containing casts, resolving airway obstruction and eliminating mortality from plastic bronchitis.

Wet granulation replaces dry compaction to produce uniform monensin granules for accurate volumetric dosing.

Chimeric compounds fuse cytokines with targeting groups to modulate protein levels via ubiquitin-mediated proteolysis, reducing systemic side effects.

Dual acid system maintains LABA stability in uncoated aluminum canisters, eliminating the need for expensive fluoropolymer coatings.

Glycerin extraction isolates beneficial cannabinoids from plant material, eliminating anxiety side effects while maintaining medical efficacy.

A cannabinoid inhaler delivers respirable droplets via a breath-operated outlet valve, resolving variable dosing and toxin production from thermal vaporization.

A homeopathic composition using nux vomica and calcarea carbonicum promotes weight loss.

Liquid simvastatin formulation maintains bioavailability and stability while eliminating overdose risks from crushing solid dosage forms.

A nutritional composition of hydrolysed whey protein and medium chain triglycerides reduces tumor growth while minimizing chemotherapy side effects.

Ultrasonic extraction resolves low viscosity trade-offs in Panax notoginseng and Bletilla striata oral liquids, enhancing hepatoprotective efficacy.

Inorganic nitrate increases nitric oxide production through non-enzymatic pathways to enhance muscular efficiency.

A lipid nanoparticle system delivers siRNA and anticancer agents to target cancer cells.

MDI formulation adds wax and terpenes to cannabinoid mixtures, resolving user comfort issues caused by traditional propellants.

A PEGylated CCR3 peptide analog induces receptor internalization and degradation to block chemotaxis.

Supercritical fluid extraction isolates cannabinoids from plant matter, enabling consistent dosing in low-calorie tea formulations.

Computer-based nebulizer system integrates breath analysis and piezoelectric vaporization for personalized therapeutic delivery.

Sequential mixing with vacuum degasification stabilizes bismuth pharmaceutical suspensions while reducing batch time and waste from air incorporation.

Phenoxy-piperidine histamine H3 antagonists replace basic nitrogen rings with non-basic heterocycles to maintain receptor affinity.

Patsnap Eureka TRIZ case analyzing a purified lactic acid bacterial cell culture composition designed to increase defecation frequency.

A sugarcane juice processing method stabilizes pH and controls temperature to preserve active compounds during extraction.

Stabilizing compounds bind the GLP-1 receptor to prevent aggregation, enabling high-resolution structural determination for drug development.

Silane chemistry generates hydroiodic acid to iodinate fatty acids, eliminating chlorine contamination and improving radiopacity.

Magnetic nanoparticle-lipid composites resolve stability-biocompatibility trade-offs by delivering high MR contrast and targeted therapeutic efficacy.

Oral compositions combine lectins, marine polysaccharides, and cannabinoids to rapidly dissolve in the mouth.